Harel Insurance Investments & Financial Services Ltd. Increases Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Harel Insurance Investments & Financial Services Ltd. raised its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 56.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,867 shares of the biotechnology company’s stock after purchasing an additional 2,111 shares during the period. Harel Insurance Investments & Financial Services Ltd.’s holdings in Axon Enterprise were worth $3,487,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Groupama Asset Managment purchased a new position in shares of Axon Enterprise during the 3rd quarter valued at about $200,000. Massachusetts Financial Services Co. MA purchased a new stake in shares of Axon Enterprise in the 3rd quarter valued at $120,553,000. International Assets Investment Management LLC bought a new position in shares of Axon Enterprise during the 3rd quarter valued at $871,860,000. Westfield Capital Management Co. LP raised its position in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares during the period. Finally, Assenagon Asset Management S.A. lifted its stake in Axon Enterprise by 328.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after purchasing an additional 111,405 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Down 0.5 %

Shares of Axon Enterprise stock opened at $610.32 on Friday. Axon Enterprise, Inc. has a 1 year low of $247.04 and a 1 year high of $698.67. The firm has a market cap of $46.54 billion, a price-to-earnings ratio of 157.71, a PEG ratio of 6.09 and a beta of 1.04. The company has a 50-day moving average of $617.65 and a 200 day moving average of $469.56. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Needham & Company LLC boosted their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. TD Cowen initiated coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective for the company. JMP Securities upped their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Robert W. Baird raised their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Finally, The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and an average price target of $504.92.

Insiders Place Their Bets

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, President Joshua Isner sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the transaction, the president now owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. The trade was a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 50,545 shares of company stock worth $30,721,337. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.